PRAC carries out safety assessment duties at its 28 September - 1 October meeting
The Pharmacovigilance Risk Assessment Committee (PRAC) reviewed 9 safety signals, 85 periodic safety update reports, 49 risk management plans and 16 post-authorisation safety studies. No referral procedures were started, ongoing or concluded during the meeting.
Primary source
EMA news release, October 2, 2026
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 September - 1 October
Read the source: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 September - 1 October ema.europa.eu
Machine-summarized from the source above; not independently reported. How we use automation